LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

Inicio・Lista de Acciones・NeoGenomics Inc

NeoGenomics Inc

Abierto

11.65 3.28

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

11.2

Máximo

11.81

Métricas clave
By Trading Economics
Ingresos	-7.2M -17M
Ventas	-3.5M 187M
BPA	0.01
Margen de beneficios	-9.164
Empleados	2,500
EBITDA	-5.8M -567K

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+30.51% upside

Dividendos
By Dow Jones
Próximas Ganancias	28 jul 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	305M 1.4B
Apertura anterior	8.37
Cierre anterior	11.65

NeoGenomics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

9 jun 2026, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

9 jun 2026, 20:09 UTC

Charlas de Mercado

Cryptocurrency Traders Look for Bitcoin Bottom -- Market Talk

9 jun 2026, 16:34 UTC

Charlas de Mercado

Cryptocurrency Weakness Follows Selling in Equities -- Market Talk

9 jun 2026, 16:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

9 jun 2026, 14:44 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

9 jun 2026, 14:44 UTC

Charlas de Mercado

Short-Term BTC Holders Have Worst Week Since 2015 -- Market Talk

9 jun 2026, 14:27 UTC

Charlas de Mercado

Outflows Slow But Don't Stop for Bitcoin ETFs -- Market Talk

9 jun 2026, 13:46 UTC

Charlas de Mercado

Privacy Coins Extend Rebound While BTC Falls -- Market Talk

9 jun 2026, 09:24 UTC

Charlas de Mercado

Bitcoin Needs Much Weaker Dollar to Stage Decent Recovery -- Market Talk

9 jun 2026, 06:50 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

9 jun 2026, 06:50 UTC

Charlas de Mercado

Bitcoin Falls Slightly as It Struggles to Recover From Recent Selloff -- Market Talk

8 jun 2026, 17:29 UTC

Charlas de Mercado

Crypto Market Still Stays in 'Extreme Fear' Amid Rebound -- Market Talk

8 jun 2026, 17:29 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

8 jun 2026, 16:40 UTC

Charlas de Mercado

Cryptocurrencies Rise After Iran and Israel Halt Exchanges of Fire -- Market Talk

8 jun 2026, 13:40 UTC

Charlas de Mercado

Crypto Shows Turnaround After Prolonged Losing Streak -- Market Talk

8 jun 2026, 03:59 UTC

Charlas de Mercado

Bitcoin Rises as Investors Focus on Long-Term Demand Drivers -- Market Talk

5 jun 2026, 18:34 UTC

Charlas de Mercado

Hyperliquid ETFs Have Inflows Despite Crypto Weakness -- Market Talk

5 jun 2026, 16:20 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

5 jun 2026, 15:16 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

5 jun 2026, 15:16 UTC

Charlas de Mercado

Zcash Tumbles After Exploit Found -- Market Talk

5 jun 2026, 14:18 UTC

Charlas de Mercado

Bitcoin Breaks Streak of ETF Outflows -- Market Talk

5 jun 2026, 13:42 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

5 jun 2026, 13:42 UTC

Charlas de Mercado

Zcash Sheds 31% as Cryptocurrency Plummets -- Market Talk

5 jun 2026, 07:12 UTC

Charlas de Mercado

Cryptocurrencies Fall Sharply as Selloff Continues -- Market Talk

4 jun 2026, 17:09 UTC

Charlas de Mercado

Retest of $55k Seen Possible for Bitcoin -- Market Talk

4 jun 2026, 16:46 UTC

Charlas de Mercado

Strategy BTC Sale Continues to Weigh on Prices -- Market Talk

4 jun 2026, 09:20 UTC

Charlas de Mercado

Ether Stays Under Pressure, Underpeforming Bitcoin -- Market Talk

4 jun 2026, 07:23 UTC

Charlas de Mercado

Bitcoin Remains Weak on Geopolitical Uncertainty, U.S. Rate-Rise Bets -- Market Talk

4 jun 2026, 03:02 UTC

Charlas de Mercado

Bitcoin Slips Amid Risk-Off Sentiment -- Market Talk

3 jun 2026, 18:24 UTC

Charlas de Mercado

New Bitcoin Support Level at $65k -- Market Talk

Comparación entre iguales

Cambio de precio

NeoGenomics Inc previsión

Precio Objetivo

By TipRanks

30.51% repunte

Estimación a 12 Meses

Media 14.93 USD 30.51%

Máximo 25 USD

Mínimo 11 USD

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para NeoGenomics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

10 ratings

Comprar

Mantener

Vender

De acuerdo con 10 analistas que ofrecen calificaciones bursátiles a para NeoGenomics Inc Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.